← Eichor
Study identifier: NCT07637500 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Refocus VisAbility™ Micro Insert System Pre-market Clinical Trial

Condition: Presbyopia  ·  Sponsor: Refocus Group, Inc.

PhaseNA
Planned participants33
Who can joinAll sexes, 45 Years to 60 Years
Healthy volunteersNo

About this study

The primary study objective is to evaluate the safety and effectiveness of the VisAbility™ Micro Insert System for improvement in binocular distance corrected near visual acuity in presbyopic patients.

This description comes directly from the study's public registry record.

Talk to the study team

Safia Ayachi  ·  +3388308811  ·  safia@medevise-consulting.com

Always discuss trial participation with your own doctor first.

Locations (1)

Universitäts-Augenklinik HeidelbergHeidelberg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07637500